Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20175955rdf:typepubmed:Citationlld:pubmed
pubmed-article:20175955lifeskim:mentionsumls-concept:C0439660lld:lifeskim
pubmed-article:20175955lifeskim:mentionsumls-concept:C1833672lld:lifeskim
pubmed-article:20175955lifeskim:mentionsumls-concept:C0023206lld:lifeskim
pubmed-article:20175955lifeskim:mentionsumls-concept:C0079380lld:lifeskim
pubmed-article:20175955lifeskim:mentionsumls-concept:C1428183lld:lifeskim
pubmed-article:20175955lifeskim:mentionsumls-concept:C0487602lld:lifeskim
pubmed-article:20175955lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:20175955lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:20175955lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:20175955lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:20175955pubmed:issue2lld:pubmed
pubmed-article:20175955pubmed:dateCreated2010-2-23lld:pubmed
pubmed-article:20175955pubmed:abstractTextWe present a comprehensive report of two siblings with hereditary inclusion body myopathy (HIBM). The clinical features and histological characteristics of the muscle biopsies showed the typical pattern of predominantly distal vacuolar myopathy with quadriceps sparing. This was confirmed by muscle MRI. PNA lectin staining showed an increased signal at the sarcolemma in patient muscle sections compared to control muscle, indicating reduced sialylation of glycoconjugates. Mutation analysis revealed compound heterozygous mutations in the GNE gene, encoding the key enzyme in sialic acid synthesis UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase: a missense mutation (c.2086G > A; p.V696M) previously described in HIBM patients of Indian origin, and a novel frame shift mutation (c.1295delA; p.K432RfsX17) leading to a premature stopcodon. These findings confirmed the diagnosis of HIBM on the histological, molecular and biochemical level.lld:pubmed
pubmed-article:20175955pubmed:languageenglld:pubmed
pubmed-article:20175955pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20175955pubmed:citationSubsetIMlld:pubmed
pubmed-article:20175955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20175955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20175955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20175955pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20175955pubmed:statusMEDLINElld:pubmed
pubmed-article:20175955pubmed:issn0722-5091lld:pubmed
pubmed-article:20175955pubmed:authorpubmed-author:LammensMMlld:pubmed
pubmed-article:20175955pubmed:authorpubmed-author:GuillardMMlld:pubmed
pubmed-article:20175955pubmed:authorpubmed-author:WeversR ARAlld:pubmed
pubmed-article:20175955pubmed:authorpubmed-author:PadbergG WGWlld:pubmed
pubmed-article:20175955pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:20175955pubmed:authorpubmed-author:HuizingMMlld:pubmed
pubmed-article:20175955pubmed:authorpubmed-author:LefeberD JDJlld:pubmed
pubmed-article:20175955pubmed:authorpubmed-author:VoermansN CNClld:pubmed
pubmed-article:20175955pubmed:authorpubmed-author:DoedéeRRlld:pubmed
pubmed-article:20175955pubmed:issnTypePrintlld:pubmed
pubmed-article:20175955pubmed:volume29lld:pubmed
pubmed-article:20175955pubmed:ownerNLMlld:pubmed
pubmed-article:20175955pubmed:authorsCompleteYlld:pubmed
pubmed-article:20175955pubmed:pagination71-7lld:pubmed
pubmed-article:20175955pubmed:dateRevised2010-6-22lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:meshHeadingpubmed-meshheading:20175955...lld:pubmed
pubmed-article:20175955pubmed:articleTitleClinical features, lectin staining, and a novel GNE frameshift mutation in hereditary inclusion body myopathy.lld:pubmed
pubmed-article:20175955pubmed:affiliationDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands. n.voermans@neuro.umcn.nllld:pubmed
pubmed-article:20175955pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20175955pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:20175955pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20175955pubmed:publicationTypeResearch Support, N.I.H., Intramurallld:pubmed
entrez-gene:10020entrezgene:pubmedpubmed-article:20175955lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20175955lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20175955lld:pubmed